Centre Hospitalier Regional et Universitaire de Lille

Centre Hospitalier Regional et Universitaire de Lille is a university in Lille, France that has taken part in 39 EU-funded projects since 2008, receiving €14.3M in EU funding and leading 2 as coordinator.

EU funding received€14.3M
EU projects39
As coordinator2
Running now15
First EU project2008
Latest project2026
CountryFrance
EU registration (PIC)999587232
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Centre Hospitalier Regional et Universitaire de Lille's own share of each project, not the project's full budget.

  • Horizon 2020€6.3M · 17 projects
  • Horizon Europe€4.2M · 9 projects
  • FP7 (2007 to 2013)€3.2M · 8 projects
  • EU4Health Programme (EU4H)€716k · 4 projects
  • Erasmus+ (ERASMUS+)€0 · 1 project

Projects

39 EU-funded projects, newest first. Centre Hospitalier Regional et Universitaire de Lille led 2 of them as coordinator. Each links to the official record.

  • TWIN-XPartner

    Multimodal Digital TWINs with Generative AI for eXplainable Precision Medicine

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €854ktheir share
  • HYPEAssociated partner

    HYPE: Assessing the central influence of hyperarousal in shaping trauma outcomes.

    Horizon Europe · 2025–2027 · Project on CORDIS ↗

  • PELVITRACKPartner

    PELVIc Floor Evaluation live TRACKing – Real-time prediction of perineal trauma

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €576ktheir share
  • INTERCEPTPartner

    Verification and validation of a biomarker panel that identifies individuals at high risk to develop Crohn’s disease allowing INTERCEPTION of full-blown disease development

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €1.3Mtheir share
  • ORCHIDEEAssociated partner

    « ORCHIDEE » Project - Developing a New National Epidemiological Surveillance Hospital Network through Secondary Health Data Usage in Hospitals

    EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗

    €303ktheir share
  • EUnetCCC JAAssociated partner

    The European Comprehensive Cancer Centre Network

    EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗

    €26ktheir share
  • ENDEAVORPartner

    Endoscopic brush cytology and single cell clinal dynamics of early easophageal adenocarcinoma for detecting cost effective surveillance strategies and prediction of cancer recurrence

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €400ktheir share
  • French_HealthData_EUAssociated partner

    Strengthening the services of the Health Data Hub, France’s health data access body and its integration within the European Health Data Space.

    EU4Health Programme (EU4H) · 2024–2027 · Project on the EU portal ↗

    €98ktheir share
  • FutureData4EUAssociated partner

    Training Future Big Data Experts for Europe

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

  • NeurotechEUAssociated partner

    European University of Brain and Technology

    Erasmus+ (ERASMUS+) · 2023–2027 · Project on the EU portal ↗

  • ERN ReCONNETPartner

    ERN ReCONNET Coordination and Management

    EU4Health Programme (EU4H) · 2023–2027 · Project on the EU portal ↗

    €288ktheir share
  • GRASPAssociated partner

    Antagonizing GnRH signaling as a “holistic” therapeutic strategy for Polycystic Ovary Syndrome

    Horizon Europe · 2023–2025 · Project on CORDIS ↗

  • CLAIMSPartner

    CLinical impact through AI-assisted MS care

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €269ktheir share
  • OBELISKPartner

    Fighting childhood obesity to stay healthy all over the life

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €721ktheir share
  • CorDial-SPartner

    PORTABLE AND FAST SURFACE PLASMON RESONANCE POINT-OF-CARE TEST FOR COVID-19

    Horizon 2020 · 2020–2022 · Project on CORDIS ↗

    €323ktheir share
  • SOPHIAPartner

    Stratification of Obesity Phenotypes to Optimize Future Therapy

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

    €400ktheir share
  • HBP SGA3Partner

    Human Brain Project Specific Grant Agreement 3

    Horizon 2020 · 2020–2023 · Project on CORDIS ↗

  • miniNOPartner

    Associative mechanisms linking a defective minipuberty to the appearance of mental and nonmental disorders: infantile NO replenishment as a new therapeutic possibility

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

    €742ktheir share
  • WATCHAssociated partner

    Well-Aging and the Tanycytic Control of Health

    Horizon 2020 · 2019–2026 · Project on CORDIS ↗

  • Phys2BioMedPartner

    Biomechanics in health and disease: advanced physical tools for innovative early diagnosis

    Horizon 2020 · 2019–2022 · Project on CORDIS ↗

  • HBP SGA2Partner

    Human Brain Project Specific Grant Agreement 2

    Horizon 2020 · 2018–2020 · Project on CORDIS ↗

    €116ktheir share
  • CARAMBAPartner

    SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma – a rare hematologic disease

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €250ktheir share
  • ICEIPartner

    Interactive Computing E-Infrastructure for the Human Brain Project

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

  • PEVIAPartner

    PAN EBOLA VACCINE INNOVATIVE APPROACH – Sofia ref.: 116088

    Horizon 2020 · 2017–2023 · Project on CORDIS ↗

    €603ktheir share
  • REPRODAMHAssociated partner

    Extra-gonadal roles of Anti-Müllerian Hormone in the aetiology of polycystic ovary syndrome: the domino effect to reproductive neuroendocrine dysfunctions

    Horizon 2020 · 2017–2023 · Project on CORDIS ↗

  • Keep ControlPartner

    Industrial Academic Initial Training Network towards specific diagnosis and treatment of age-related gait and balance deficits

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

    €263ktheir share
  • PAPA-ARTISAssociated partner

    Paraplegia Prevention in Aortic Aneurysm Repair by Thoracoabdominal Staging with ‘Minimally-Invasive Segmental Artery Coil-Embolization’: A Randomized Controlled Multicentre Trial

    Horizon 2020 · 2017–2024 · Project on CORDIS ↗

  • RHAPSODYPartner

    Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification - Sofia ref.: 115881

    Horizon 2020 · 2016–2021 · Project on CORDIS ↗

    €299ktheir share
  • HBP SGA1Partner

    Human Brain Project Specific Grant Agreement 1

    Horizon 2020 · 2016–2018 · Project on CORDIS ↗

  • H2020MM04Partner

    DC-based immunotherapy to treat Malignant Mesothelioma

    Horizon 2020 · 2016–2021 · Project on CORDIS ↗

    €660ktheir share
  • FAIR-PARK-IICoordinator

    Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone

    Horizon 2020 · 2015–2021 · Project on CORDIS ↗

    €2.6Mtheir share
  • MON4STRATPartner

    Therapeutic Beta-Lactam Monitoring for Stratified Treatment of hospital-acquired pneumonia, improved dose-dependent efficacy, decreased treatment duration, and prevention of emergence of resistance

    FP7 (2007 to 2013) · 2014–2019 · Project on CORDIS ↗

    €251ktheir share
  • DIRECTPartner

    DIabetes REsearCh on patient sTratification

    FP7 (2007 to 2013) · 2012–2019 · Project on CORDIS ↗

    €201ktheir share
  • EUROHYP-1Partner

    European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke

    FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗

    €303ktheir share
  • NILVADPartner

    A European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer’s disease

    FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

    €428ktheir share
  • PEVNETPartner

    Persistent virus infection as a cause of pathogenic inflammation in type 1 diabetes - an innovative research program of biobanks and expertise

    FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

    €348ktheir share
  • MITOTARGETPartner

    Mitochondrial dysfunction in neurodegenerative diseases: towards new therapeutics

    FP7 (2007 to 2013) · 2009–2012 · Project on CORDIS ↗

    €73ktheir share
  • LOULLA&PHILLAPartner

    Development of 6-mercaptopurine and Methotrexate oral liquid formulations for the maintenance treatment of Acute Lymphoblastic Leukæmia in children

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €48ktheir share
  • PSIPCoordinator

    PATIENT SAFETY THROUGH INTELLIGENT PROCEDURES IN MEDICATION

    FP7 (2007 to 2013) · 2008–2011 · Project on CORDIS ↗

    €1.5Mtheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • adverse drug reactions
  • agriculture
  • alkaline earth metals
  • alzheimer
  • amyotrophic lateral sclerosis
  • antibiotics
  • antivirals
  • artificial intelligence
  • big data
  • bioeconomy
  • biophysics
  • cardiology
  • cardiovascular diseases
  • cells technologies

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime